Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EV/Core EBITDA

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 19.4831.1331.3232.6710.70

What is the latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH ?

The latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH is 19.48 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202419.48
Mar202331.13
Mar202231.32
Mar202132.67
Mar202010.70

How is EV/Core EBITDA of MEDICAMEN BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2024 19.48
-37.42
Mar2023 31.13
-0.61
Mar2022 31.32
-4.13
Mar2021 32.67
205.33
Mar2020 10.7 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EV/Core EBITDA ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹514.9 Cr -2.5% -4.9% -5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,478.0 Cr -6.5% -4.7% -5.1% Stock Analytics
DIVIS LABORATORIES ₹162,845.0 Cr -7.1% -11.5% 32.7% Stock Analytics
CIPLA ₹120,121.0 Cr -4.3% -0.1% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,327.0 Cr -5.8% 6.1% 13.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,907.8 Cr -5.8% -6.8% -11% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-2.5%

-4.9%

-5%

SENSEX

-1.2%

-3.5%

-0.5%


You may also like the below Video Courses